<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30061232</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>08</Month>            <Day>06</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>06</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1791-7530</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>38</Volume>                    <Issue>8</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                    </PubDate>                </JournalIssue>                <Title>Anticancer research</Title>                <ISOAbbreviation>Anticancer Res.</ISOAbbreviation>            </Journal>            <ArticleTitle>Evaluation of Injectable Chitosan-based Co-cross-linking Hydrogel for Local Delivery of <sup>188</sup>Re-LIPO-DOX to Breast-tumor-bearing Mouse Model.</ArticleTitle>            <Pagination>                <MedlinePgn>4651-4659</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.21873/anticanres.12770</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">An injectable chitosan-based co-cross-linking thermosensitive hydrogel combining <sup>188</sup>Re- and doxorubicin-encapsulated liposomes (C/GP/GE/<sup>188</sup>Re-LIPO-DOX) was developed for the prevention of locoregional recurrence after mastectomy.</AbstractText>                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The hydrogel properties, in vitro drug release characteristics, and in vivo scintigraphy imaging attributes were investigated.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The gelation time of the hydrogels can be controlled to be within 5 min. Results from Fourier-transform infrared spectroscopy, scanning electron microscopy, and dynamic mechanical analysis showed that a covalent cross-linking reaction between chitosan and genipin occurred and that the hydrogel's mechanical strength and chemical stability were improved. In vitro drug release studies showed that the hydrogel can prolong the release of doxorubicin by several weeks (51.5%±5.3% at 21 days). In addition, in vivo scintigraphy results suggested high retention rates (43.1%±1.0% at 48 h) of the radiopharmaceutical compound at the tumor injection site.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The preliminary results indicated that the C/GP/GE/<sup>188</sup>Re-LIPO-DOX radiopharmaceutical hydrogel is a potential candidate for further in vivo therapeutic evaluation.</AbstractText>                <CopyrightInformation>Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Huang</LastName>                    <ForeName>Feng-Yun J</ForeName>                    <Initials>FJ</Initials>                    <AffiliationInfo>                        <Affiliation>Nuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu, Taiwan, R.O.C.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hung</LastName>                    <ForeName>Cheng-Chien</ForeName>                    <Initials>CC</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Nuclear Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan, R.O.C.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chang</LastName>                    <ForeName>Chien-Wen</ForeName>                    <Initials>CW</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan, R.O.C.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chao</LastName>                    <ForeName>Jiunn-Hsing</ForeName>                    <Initials>JH</Initials>                    <AffiliationInfo>                        <Affiliation>Nuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu, Taiwan, R.O.C.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hsieh</LastName>                    <ForeName>Bor-Tsung</ForeName>                    <Initials>BT</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C. bthsieh@ctust.edu.tw.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Greece</Country>            <MedlineTA>Anticancer Res</MedlineTA>            <NlmUniqueID>8102988</NlmUniqueID>            <ISSNLinking>0250-7005</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D020100">Hydrogels</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D039823">Iridoids</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011868">Radioisotopes</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C000615081">Rhenium-188</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C506643">liposomal doxorubicin</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>30IQX730WE</RegistryNumber>                <NameOfSubstance UI="D011092">Polyethylene Glycols</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>7440-15-5</RegistryNumber>                <NameOfSubstance UI="D012211">Rhenium</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>80168379AG</RegistryNumber>                <NameOfSubstance UI="D004317">Doxorubicin</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>9012-76-4</RegistryNumber>                <NameOfSubstance UI="D048271">Chitosan</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>A3V2NE52YG</RegistryNumber>                <NameOfSubstance UI="C007834">genipin</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D048271" MajorTopicYN="N">Chitosan</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004317" MajorTopicYN="N">Doxorubicin</DescriptorName>                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016503" MajorTopicYN="N">Drug Delivery Systems</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D065546" MajorTopicYN="N">Drug Liberation</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D020100" MajorTopicYN="N">Hydrogels</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007267" MajorTopicYN="N">Injections</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D039823" MajorTopicYN="N">Iridoids</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011092" MajorTopicYN="N">Polyethylene Glycols</DescriptorName>                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011868" MajorTopicYN="N">Radioisotopes</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019275" MajorTopicYN="N">Radiopharmaceuticals</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012211" MajorTopicYN="N">Rhenium</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017550" MajorTopicYN="N">Spectroscopy, Fourier Transform Infrared</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">188Re-liposome; doxorubicin (DOX)</Keyword>            <Keyword MajorTopicYN="N">Chitosan/β-glycerophosphate (C/GP)</Keyword>            <Keyword MajorTopicYN="N">breast tumor</Keyword>            <Keyword MajorTopicYN="N">genipin (GE)</Keyword>            <Keyword MajorTopicYN="N">hydrogel</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30061232</ArticleId>            <ArticleId IdType="pii">38/8/4651</ArticleId>            <ArticleId IdType="doi">10.21873/anticanres.12770</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>